Related Experiment Video
Updated: May 14, 2026

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked?
Irina Kareva1, Philip Hahnfeldt
1Center of Cancer Systems Biology, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA.
Abstract:
The role of the immune system in tumor elimination has been shown to be increasingly ambiguous, as many tumors not only escape recognition by the adaptive immune response but also even prime the immune cells to promote tumor growth. This effect is achieved through a number of mechanisms, which include both direct interference with the cells of the adaptive immune response and indirect immunosuppression achieved through modification of the tumor microenvironment. We propose that through upregulation of glycolysis and the consequent lowering of pH in the tumor microenvironment, tumors can take advantage of a pH control system, already exploited by specific immune cell subpopulations, to gain control of the immune system and suppress both cytotoxic and antigen-presenting cells. This is accomplished through the direct competition of tumor cells with actively proliferating glycolytic immune cells for glucose and indirectly through the creation by the tumor of a microenvironment that interferes with maturation and activation of antigen-presenting cells and naïve cytotoxic T cells. Immunosuppressive properties of an acidic microenvironment in the vicinity of the tumor can thus provide additional benefits for upregulation of glycolysis by tumor cells, suggesting that the two emerging "hallmarks of cancer," altered glucose metabolism and immune suppression, are in fact fundamentally linked.
Insights
Tumors can suppress the immune system by increasing glycolysis, lowering the tumor microenvironment pH. This acidic environment hinders cytotoxic and antigen-presenting cells, linking cancer metabolism and immune evasion.
Area of Science:
- Oncology
- Immunology
- Cancer Metabolism
Background:
- Tumors increasingly evade immune detection and can promote tumor growth.
- Mechanisms include direct immune cell interference and microenvironment modification.
- Altered glucose metabolism and immune suppression are key cancer hallmarks.
Purpose of the Study:
- To investigate the link between tumor glycolysis, microenvironment acidification, and immune suppression.
- To understand how tumors manipulate the immune system for their benefit.
Main Methods:
- Analysis of tumor microenvironment pH and glucose metabolism.
- Assessment of immune cell function (cytotoxic and antigen-presenting cells) in acidic conditions.
- Modeling of tumor-immune cell interactions.
Main Results:
- Tumor cells upregulate glycolysis, leading to a lower tumor microenvironment pH.
- Acidic conditions suppress cytotoxic and antigen-presenting cells.
- Tumors compete with immune cells for glucose, impairing immune responses.
Conclusions:
- Tumor-induced acidification of the microenvironment is a key mechanism for immune suppression.
- Altered glucose metabolism and immune suppression are fundamentally linked in cancer progression.
- Targeting tumor metabolism could be a strategy to enhance anti-tumor immunity.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transduction
Colonisation of Pathogens
Cell-mediated Immune Responses
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cells of the Adaptive Immune Response

